Philipp Mews

Company: EpiVario
Job title: Co-Founder
Seminars:
Developing Small-Molecule Drugs for Epigenetic Treatments of Psychiatric Disorders 2:45 pm
Rationalizing the use of small-molecule compounds to target metabolicepigenetic pathways in the brain Blocking a metabolic enzyme controls the epigenetic encoding of maladaptive memory Preclinical models to develop epigenetic therapeutics for neuropsychiatric disordersRead more
day: Day One